We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Implantable Cardiac Device Helps Doctors Monitor Patients

By HospiMedica International staff writers
Posted on 23 Feb 2009
A new subcutaneous insertable cardiac monitor (ICM) offers important insights into patients' irregular heart rhythms, including atrial fibrillation (AF).

The Reveal XT ICM is intended for patients with suspected arrhythmias, as well as for difficult to diagnose patients for whom long-term cardiac rhythm trending data may aid in a more informed diagnosis. More...
The device is also an option for physicians seeking to detect the presence of atrial arrhythmias, including asymptomatic episodes, or to monitor the amount of time a patient is in AF to assess whether medical treatment is necessary or should be adjusted.

The ICM is placed just under the skin of the chest area in a short outpatient procedure, and captures an electrocardiogram (ECG) during the actual episode; to store an ECG, the patient places a hand-held, pager-sized digital assistant over the device, and presses a button. Later, a physician analyzes the stored information, transmitted via the CareLink Network or during an in-office patient visit, and determines whether the episode was caused by an abnormal heart rhythm. Reveal XT device data has been accessible via the CareLink Network since the fall of 2008, which helps patients stay connected with their healthcare provider from home. The network also offers physicians access to diagnostic data remotely, which may help them make timely, informed decisions. The Reveal XT ICM and the CareLink Network are products of Medtronic (Minneapolis, MN, USA).

"I see many patients desperately seeking answers for their unexplained symptoms,” said Blair Grubb, M.D., a professor of medicine and pediatrics at the University of Toledo Medical Center (OH, USA), who implanted the first device in the United States. "By adding AF detection capabilities and greater diagnostic reporting, I expect the Reveal XT device to be an even more effective tool to help monitor and diagnose my patients' cardiac conditions.”

"The Reveal XT monitor offers physicians a proven option for uncovering dangerous cardiac conditions, including atrial fibrillation. For patients experiencing arrhythmias or unexplained fainting episodes, having greater insights into the cause is incredibly valuable for both the patient and physician,” said Elizabeth Hoff, vice president and general manager of the subcutaneous diagnostics and monitoring unit of the cardiac rhythm disease management business at Medtronic.

Related Links:

Medtronic
University of Toledo Medical Center



Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
MRI System
nanoScan MRI 3T/7T
LED Surgical Lamp
ACEMST35/57
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The fiber in the brain implant is less than half a millimeter thick (Photo courtesy of Peter Aagaard Brixen)

Brain Implant Records Neural Signals and Delivers Precise Medication

Neurological diseases such as epilepsy involve complex interactions across multiple layers of the brain, yet current implants can typically stimulate or record activity from only a single point.... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.